ENGENE HOLDINGS INC (ENGN) Stock News

USA - Nasdaq - NASDAQ:ENGN - CA29286M1059 - Common Stock

8 USD

+0.14 (+1.78%)

Last: 12/3/2025, 8:22:21 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ENGN Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: enGene Holdings Inc.

enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness

9 days ago - By: enGene Holdings Inc.

enGene to Present at the Piper Sandler 37th Annual Healthcare Conference

15 days ago - By: Benzinga - Mentions: IBIO IMCC VREX IFRX ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

20 days ago - By: Benzinga - Mentions: ALKS IMMP MLSS PHIO ...

12 Health Care Stocks Moving In Thursday's After-Market Session

3 months ago - By: The Motley Fool

enGene Posts 78% Expense Jump in Q3

21 days ago - By: enGene Holdings Inc.

enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants

21 days ago - By: enGene Holdings Inc.

enGene Announces Proposed Public Offering of Common Shares

23 days ago - By: Stocktwits

ENGN Stock Soars On Hopeful Data From Bladder Cancer Study

23 days ago - By: enGene Holdings Inc.

Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months

23 days ago - By: enGene Holdings Inc.

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

a month ago - By: enGene Holdings Inc.

enGene to Participate in Upcoming Investor Conferences

a month ago - By: enGene Holdings Inc.

enGene Named a BioSpace 2026 Best Places to Work Winner

2 months ago - By: enGene Holdings Inc.

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

2 months ago - By: enGene Holdings Inc.

enGene Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer

3 months ago - By: enGene Holdings Inc.

enGene Reports Third Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: enGene Holdings Inc.

enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort

3 months ago - By: enGene Holdings Inc.

enGene to Participate in Upcoming Investor Conferences

4 months ago - By: enGene Holdings Inc.

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

5 months ago - By: enGene Holdings Inc.

enGene Announces Board and Leadership Appointments to Support Commercial Readiness

5 months ago - By: enGene Holdings Inc.

FDA Grants RMAT Designation for enGene’s Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

6 months ago - By: enGene Holdings Inc.

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

6 months ago - By: enGene Holdings Inc.

enGene Reports Second Quarter 2025 Financial Results and Provides Business Update

6 months ago - By: enGene Holdings Inc.

enGene Announces the Resignation of its Chief Medical Officer

6 months ago - By: enGene Holdings Inc.

enGene to Present at the Jefferies Global Healthcare Conference

6 months ago - By: enGene Holdings Inc.

enGene Names Amy Pott as Chief Global Commercialization Officer

7 months ago - By: enGene Holdings Inc.

enGene to Participate in Upcoming Investor Conferences

7 months ago - By: Yahoo Finance - Mentions: DHI CMG

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now?

8 months ago - By: enGene Holdings Inc.

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)